關鍵字
 
Q W E R T Y U I O P
A S D F G H J K L
Z X C V B N M
首頁
  略過巡覽連結登入系統 / 首頁 / 消息內容 檢驗醫學科網站 檢驗通告 國際標準換算 檢體採集原則 量測不確定度


4.
轉換C3,C4,IgG,IgA,IgM,RF-IgM,Haptoglobin檢驗平台
 2020.07.06

檢驗科通知

                                                  檢字 員基10922

  202076

受文者全體醫護人員

  :轉換C3C4IgGIgAIgMRF-IgMHaptoglobin檢驗平台

 

1.     202076日起,委託代檢單位異動Complement C3c (FBIC3)

  Complement C4 (FBIC4),Immunoglobulin IgG (FBIIGG)Immunoglobulin IgA

  (FBIIGA)Immunoglobulin IgM (FBIIGM)RF-IgM (FBIRA)Haptoglobin   

  (FBIHAP)以及CSF IgG indexSerum IgG(FBIIND),由Simense Atellica NEPH

  630檢驗平台轉換為Beckman Coulter AU檢驗平台。檢驗原理由免疫散射法

  (Immunonephelometry assay)轉換為免疫比濁法(Immunoturbidimetric assay),生物

  參考區間異動如下:

檢檢項目

異動前

異動後

Complement C3c

(FBIC3)

90.0~180.0 mg/dL

87.0~200.0 mg/dL

Complement C4

(FBIC4)

10~40 mg/dL

13.1~50.2 mg/dL

Immunoglobulin IgG (FBIIGG)

(1)Adult700-1,600 mg/dL

(2)Children95 % central interval:

1 year: 350.0-860.0 mg/dL(Males)

400.0-980.0 mg/dL(Females)

4 year: 510-1,260 mg/dL(Males)530.0-1,300.0 mg/dL(Females) 

7 year: 600.0-1,470.0 mg/dL

(Males)590.0-1,460.0 mg/dL(Females)

10 year: 660.0-1,620.0 mg/dL(Males)640.0-1,590 mg/dL(Females)

14 year: 660.0-1,620.0 mg/dL(Males)680.0-1,670.0 mg/dL(Females)

18 year: 650.0-1,600.0 mg/dL(Males)690.0-1,700 mg/dL(Females)

635~1741 mg/dL

Immunoglobulin IgA(FBIIGA)

(1)Adult: 70.0-400.0 mg/dL;

(2)Children: (95% central interval)

(Males)

1 year: 17.0-96.0 mg/dL,

4 year 36.0-198.0 mg/dL;

7 year 48.0-266.0 mg/dL,

10 year 57.0-318.0 mg/dL,

14 year 64.0-352.0 mg/dL,

18 year 68.0-379.0 mg/dL

(Females)

1 year 17.0-94.0 mg/dL,

4 year 33.0-185.0 mg/dL,

7 year 44.0-244.0 mg/dL,

10 year 52.0-290.0 mg/dL,

14 year 62.0-343.0 mg/dL,

18 year 69.0-380.0 mg/dL

66~433mg/dL

Immunoglobulin IgM (FBIIGM)

(1)Adult40.0-230.0 mg/dL

(2)Children95 % central interval:

1 year: 30.0-183.0 mg/dL(Males)34.0-206.0 mg/dL(Females)

4 year: 35.0-213.0 mg/dL(Males)42.0-255.0 mg/dL(Females)

7 year: 37.0-226.0 mg/dL(Males)45.0-278.0 mg/dL(Females)

10 year: 38.0-235.0 mg/dL(Males)48.0-294.0 mg/dL(Females)

14 year: 40.0-244.0 mg/dL(Males)50.0-309.0 mg/dL(Females)

18 year: 41.0-251.0 mg/dL(Males)52.0-322.0 mg/dL(Females)

Adults45~281 mg/dL

RF-IgM(FBIRA)

15.9 IU/mL

14.0 IU/mL (95th percentile)

Haptoglobin  

(FBIHAP)

30.0~200.0 mg/dL

44.0~215.0 mg/dL (Adults)

CSF IgG index

(FBIIND)

(1)Serum albumin3.5~4.8 g/dL

(2)Serum IgG

(A)成人:700-1,600 mg/dL

(B)小孩:(95%信賴區間)

男性(mg/dL)

1:350.0~860.04:510.0~1260.0

7:600.0~1470.010:660.0~1620.014:660.0~1620.018:650.0~1600.0;女性(mg/dL)

1:400.0~980.04:530.0~1300.0

7:590.0~1460.010:640.0~1590.014:680.0~1670.018:690.0~1700.0 (3)CSF IgG:<3.4 mg/dL

(4)CSF Albumin:<35.0 mg/dL

(5)IgG index:<0.8

(1)Serum albumin3.5~5.7 g/dL

(2)Serum IgG635~1741 mg/dL

(3)CSF IgG:<3.4 mg/dL

(4)CSF Albumin:<35.0 mg/dL

(5)IgG index:<0.8

(6) CSF/serum albumin index:<0.9

2.     異動之檢驗項目採檢相關注意事項,包含病人準備、採檢及傳送方式、報

  告完成時間及生物參考區間等,請參考本院主網頁檢驗資訊查詢系統。  

  (http://172.24.19.114:8080/LabSearch/)

3.     相關訊息可洽:1046檢驗諮詢專線、1045品管教研組

 

檢驗科主任醫檢師 陳裕娟



 
  財團法人彰化基督教醫院 無標題文件
網站瀏覽人數:201144   線上人數:1